Daiichi Sankyo
Krystal Saintil is a seasoned professional in clinical research and project management with over a decade of experience in the pharmaceutical industry. Currently serving as a Senior Clinical Study Manager at Daiichi Sankyo, Inc. since May 2021, Krystal previously held positions at Bristol Myers Squibb as a Project Manager in US Medical Affairs, and as a Global Clinical Lead at Ipsen. Notably, Krystal contributed significantly to Novartis Oncology, taking on various roles including Medical Launch Excellence Project Manager and Clinical Research Scientist, showcasing expertise in hematology and oncology. Educationally, Krystal holds a Bachelor of Arts in Biology from Kean University, obtained in 2013.
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.